|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:BSG-SHC2 (FusionGDB2 ID:10398) |
Fusion Gene Summary for BSG-SHC2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: BSG-SHC2 | Fusion gene ID: 10398 | Hgene | Tgene | Gene symbol | BSG | SHC2 | Gene ID | 682 | 25759 |
| Gene name | basigin (Ok blood group) | SHC adaptor protein 2 | |
| Synonyms | 5F7|CD147|EMMPRIN|EMPRIN|OK|SLC7A11|TCSF | SCK|SHCB|SLI | |
| Cytomap | 19p13.3 | 19p13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | basiginOK blood group antigencollagenase stimulatory factorextracellular matrix metalloproteinase inducerleukocyte activation antigen M6tumor cell-derived collagenase stimulatory factor | SHC-transforming protein 2SH2 domain protein C2SHC (Src homology 2 domain containing) transforming protein 2SHC-transforming protein Bneuronal Shc adaptor homologprotein Scksrc homology 2 domain-containing-transforming protein C2 | |
| Modification date | 20200315 | 20200313 | |
| UniProtAcc | P35613 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000333511, ENST00000353555, ENST00000346916, ENST00000545507, ENST00000574970, | ENST00000264554, | |
| Fusion gene scores | * DoF score | 26 X 17 X 12=5304 | 7 X 4 X 7=196 |
| # samples | 29 | 7 | |
| ** MAII score | log2(29/5304*10)=-4.19295597009765 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/196*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: BSG [Title/Abstract] AND SHC2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | BSG(572701)-SHC2(425231), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across BSG (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across SHC2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LIHC | TCGA-G3-A6UC-01A | BSG | chr19 | 572701 | + | SHC2 | chr19 | 425231 | - |
Top |
Fusion Gene ORF analysis for BSG-SHC2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000333511 | ENST00000264554 | BSG | chr19 | 572701 | + | SHC2 | chr19 | 425231 | - |
| In-frame | ENST00000353555 | ENST00000264554 | BSG | chr19 | 572701 | + | SHC2 | chr19 | 425231 | - |
| intron-3CDS | ENST00000346916 | ENST00000264554 | BSG | chr19 | 572701 | + | SHC2 | chr19 | 425231 | - |
| intron-3CDS | ENST00000545507 | ENST00000264554 | BSG | chr19 | 572701 | + | SHC2 | chr19 | 425231 | - |
| intron-3CDS | ENST00000574970 | ENST00000264554 | BSG | chr19 | 572701 | + | SHC2 | chr19 | 425231 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000333511 | BSG | chr19 | 572701 | + | ENST00000264554 | SHC2 | chr19 | 425231 | - | 1457 | 137 | 70 | 711 | 213 |
| ENST00000353555 | BSG | chr19 | 572701 | + | ENST00000264554 | SHC2 | chr19 | 425231 | - | 1444 | 124 | 57 | 698 | 213 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000333511 | ENST00000264554 | BSG | chr19 | 572701 | + | SHC2 | chr19 | 425231 | - | 0.007235544 | 0.9927644 |
| ENST00000353555 | ENST00000264554 | BSG | chr19 | 572701 | + | SHC2 | chr19 | 425231 | - | 0.007299139 | 0.9927008 |
Top |
Fusion Genomic Features for BSG-SHC2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for BSG-SHC2 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:572701/chr19:425231) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| BSG | . |
| FUNCTION: [Isoform 1]: Essential for normal retinal maturation and development (By similarity). Acts as a retinal cell surface receptor for NXNL1 and plays an important role in NXNL1-mediated survival of retinal cone photoreceptors (PubMed:25957687). In association with glucose transporter SLC16A1/GLUT1 and NXNL1, promotes retinal cone survival by enhancing aerobic glycolysis and accelerating the entry of glucose into photoreceptors (PubMed:25957687). May act as a potent stimulator of IL6 secretion in multiple cell lines that include monocytes (PubMed:21620857). {ECO:0000250|UniProtKB:P18572, ECO:0000269|PubMed:21620857, ECO:0000269|PubMed:25957687}.; FUNCTION: [Isoform 2]: Signaling receptor for cyclophilins, essential for PPIA/CYPA and PPIB/CYPB-dependent signaling related to chemotaxis and adhesion of immune cells (PubMed:11943775, PubMed:11688976). Plays an important role in targeting monocarboxylate transporters SLC16A1/GLUT1, SLC16A11 and SLC16A12 to the plasma membrane (PubMed:17127621, PubMed:21778275, PubMed:28666119). Acts as a coreceptor for vascular endothelial growth factor receptor 2 (KDR/VEGFR2) in endothelial cells enhancing its VEGFA-mediated activation and downstream signaling (PubMed:25825981). Promotes angiogenesis through EPAS1/HIF2A-mediated up-regulation of VEGFA (isoform VEGF-165 and VEGF-121) and KDR/VEGFR2 in endothelial cells (PubMed:19837976). Plays a key role in regulating tumor growth, invasion, metastasis and neoangiogenesis by stimulating the production and release of extracellular matrix metalloproteinases and KDR/VEGFR2 by both tumor cells and stromal cells (fibroblasts and endothelial cells) (PubMed:12553375, PubMed:11992541, PubMed:15833850). {ECO:0000269|PubMed:11688976, ECO:0000269|PubMed:11943775, ECO:0000269|PubMed:11992541, ECO:0000269|PubMed:12553375, ECO:0000269|PubMed:15833850, ECO:0000269|PubMed:17127621, ECO:0000269|PubMed:19837976, ECO:0000269|PubMed:21778275, ECO:0000269|PubMed:25825981, ECO:0000269|PubMed:28666119}.; FUNCTION: [Isoform 1]: (Microbial infection) Erythrocyte receptor for P.falciparum RH5 which is essential for erythrocyte invasion by the merozoite stage of P.falciparum isolates 3D7 and Dd2. {ECO:0000269|PubMed:22080952}.; FUNCTION: [Isoform 2]: (Microbial infection) Erythrocyte receptor for P.falciparum RH5 which is essential for erythrocyte invasion by the merozoite stage of P.falciparum isolates 3D7, Dd2, 7G8 and HB3 (PubMed:22080952, PubMed:26195724). Binding of P.falciparum RH5 results in BSG dimerization which triggers an increase in intracellular Ca(2+) in the erythrocyte (PubMed:28409866). This essential step leads to a rearrangement of the erythrocyte cytoskeleton required for the merozoite invasion (PubMed:28409866). {ECO:0000269|PubMed:22080952, ECO:0000269|PubMed:26195724, ECO:0000269|PubMed:28409866}.; FUNCTION: [Isoform 2]: (Microbial infection) Can facilitate human SARS coronavirus (SARS-CoV-1) infection via its interaction with virus-associated PPIA/CYPA. {ECO:0000269|PubMed:15688292}.; FUNCTION: [Isoform 2]: (Microbial infection) Can facilitate HIV-1 infection via its interaction with virus-associated PPIA/CYPA. {ECO:0000269|PubMed:11353871}.; FUNCTION: [Isoform 2]: (Microbial infection) First described as a receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is not required for SARS-CoV-2 infection. {ECO:0000269|PubMed:33432067, ECO:0000303|PubMed:32307653}.; FUNCTION: [Isoform 2]: (Microbial infection) Acts as a receptor for measles virus. {ECO:0000269|PubMed:20147391}.; FUNCTION: [Isoform 2]: (Microbial infection) Promotes entry of pentamer-expressing human cytomegalovirus (HCMV) into epithelial and endothelial cells. {ECO:0000269|PubMed:29739904}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | SHC2 | chr19:572701 | chr19:425231 | ENST00000264554 | 8 | 13 | 487_578 | 391 | 694.6666666666666 | Domain | SH2 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000333511 | + | 1 | 9 | 356_359 | 22 | 587.3333333333334 | Compositional bias | Note=Poly-Asp |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000346916 | + | 1 | 7 | 356_359 | 0 | 359.6666666666667 | Compositional bias | Note=Poly-Asp |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000353555 | + | 1 | 8 | 356_359 | 22 | 476.6666666666667 | Compositional bias | Note=Poly-Asp |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000545507 | + | 1 | 8 | 356_359 | 0 | 333.3333333333333 | Compositional bias | Note=Poly-Asp |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000333511 | + | 1 | 9 | 138_219 | 22 | 587.3333333333334 | Domain | Ig-like C2-type |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000333511 | + | 1 | 9 | 221_315 | 22 | 587.3333333333334 | Domain | Ig-like V-type |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000333511 | + | 1 | 9 | 37_120 | 22 | 587.3333333333334 | Domain | Ig-like |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000346916 | + | 1 | 7 | 138_219 | 0 | 359.6666666666667 | Domain | Ig-like C2-type |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000346916 | + | 1 | 7 | 221_315 | 0 | 359.6666666666667 | Domain | Ig-like V-type |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000346916 | + | 1 | 7 | 37_120 | 0 | 359.6666666666667 | Domain | Ig-like |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000353555 | + | 1 | 8 | 138_219 | 22 | 476.6666666666667 | Domain | Ig-like C2-type |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000353555 | + | 1 | 8 | 221_315 | 22 | 476.6666666666667 | Domain | Ig-like V-type |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000353555 | + | 1 | 8 | 37_120 | 22 | 476.6666666666667 | Domain | Ig-like |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000545507 | + | 1 | 8 | 138_219 | 0 | 333.3333333333333 | Domain | Ig-like C2-type |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000545507 | + | 1 | 8 | 221_315 | 0 | 333.3333333333333 | Domain | Ig-like V-type |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000545507 | + | 1 | 8 | 37_120 | 0 | 333.3333333333333 | Domain | Ig-like |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000333511 | + | 1 | 9 | 138_323 | 22 | 587.3333333333334 | Topological domain | Extracellular |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000333511 | + | 1 | 9 | 345_385 | 22 | 587.3333333333334 | Topological domain | Cytoplasmic |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000346916 | + | 1 | 7 | 138_323 | 0 | 359.6666666666667 | Topological domain | Extracellular |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000346916 | + | 1 | 7 | 345_385 | 0 | 359.6666666666667 | Topological domain | Cytoplasmic |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000353555 | + | 1 | 8 | 138_323 | 22 | 476.6666666666667 | Topological domain | Extracellular |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000353555 | + | 1 | 8 | 345_385 | 22 | 476.6666666666667 | Topological domain | Cytoplasmic |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000545507 | + | 1 | 8 | 138_323 | 0 | 333.3333333333333 | Topological domain | Extracellular |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000545507 | + | 1 | 8 | 345_385 | 0 | 333.3333333333333 | Topological domain | Cytoplasmic |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000333511 | + | 1 | 9 | 324_344 | 22 | 587.3333333333334 | Transmembrane | Helical |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000346916 | + | 1 | 7 | 324_344 | 0 | 359.6666666666667 | Transmembrane | Helical |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000353555 | + | 1 | 8 | 324_344 | 22 | 476.6666666666667 | Transmembrane | Helical |
| Hgene | BSG | chr19:572701 | chr19:425231 | ENST00000545507 | + | 1 | 8 | 324_344 | 0 | 333.3333333333333 | Transmembrane | Helical |
| Tgene | SHC2 | chr19:572701 | chr19:425231 | ENST00000264554 | 8 | 13 | 147_329 | 391 | 694.6666666666666 | Domain | PID | |
| Tgene | SHC2 | chr19:572701 | chr19:425231 | ENST00000264554 | 8 | 13 | 330_486 | 391 | 694.6666666666666 | Region | Note=CH1 |
Top |
Fusion Gene Sequence for BSG-SHC2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >10398_10398_1_BSG-SHC2_BSG_chr19_572701_ENST00000333511_SHC2_chr19_425231_ENST00000264554_length(transcript)=1457nt_BP=137nt GCTTTTTATAGCGGCCGCGGGCGGCGGCGGCAGCGGTTGGAGGTTGTAGGACCGGCGAGGAATAGGAATCATGGCGGCTGCGCTGTTCGT GCTGCTGGGATTCGCGCTGCTGGGCACCCACGGAGCCTCCGGGGCTGCTCCACCGGGGGACGGCTACGTGCAGGCGGACGCCCGGGGCCC CCCGGACCACGAGGAGCACCTGTATGTCAACACCCAGGGTCTGGACGCCCCCGAGCCGGAGGACAGCCCCAAAAAGGATCTGTTTGACAT GCGACCCTTTGAGGATGCCCTGAAGTTGCATGAGTGCTCAGTGGCGGCAGGCGTGACAGCAGCCCCTCTTCCCTTGGAGGACCAGTGGCC CAGCCCCCCTACCCGCCGGGCCCCTGTGGCCCCCACGGAGGAACAGCTGCGTCAGGAGCCCTGGTACCACGGCCGGATGAGCCGCCGGGC GGCAGAGAGGATGCTTCGAGCTGACGGGGACTTCCTTGTGCGAGACAGCGTCACCAACCCCGGGCAGTATGTCCTCACCGGCATGCACGC CGGGCAGCCCAAGCACCTGCTGCTCGTGGACCCCGAGGGCGTGGTACGGACGAAGGACGTGCTGTTTGAGAGCATCAGCCACCTGATCGA CCACCACCTGCAGAACGGGCAGCCCATCGTGGCCGCCGAGAGTGAGCTGCACCTGCGTGGCGTGGTCTCACGGGAGCCCTGAGCCAGGTG ACCGTTCTCAGCCCTGGCTCCTGCCTGTTCTCAGCCCCGGCTCCTGCCTGTCATGGCCTTGGGGCTCTCAGCCCTCCTCCTGGATCCTGG TCAGGCCGAACCACCGCTGCCTCTCCTTCCTCCGCATGAGCCTCTGGCATGGTCCTTCCTCCAGCTGGCCCCGGGCTGGGCAGAGCCTCC TCCTGCCGGGGCCCCTGCCCACCCCCTCCTTTGCCTGGAGTGAGGGTGTTCATACCAAAGACGGAACCATTTCGCCTTTAAAGAAAATAT ATCCAGAAGCAGCCGCTGCCTCGGAGCCCTGGCCCTTGGGTCCCCCTCTCGCCTGGCTGGTTCGGTCTAACGCCCCGGAGAGTCAGGGCT CCCAGGACCCTGGGGAGGAGGCGGATTCCGGGCCTGGCTGGGCTTCCTCTTCCCACCTGAGGACTGGGTGCACAGTTGTCTTTGAGGGGG GACGCTTAAGGTGCTTTGGGGTTCTCAGGCCAGGATACATGCTGGCGCTGAAGTGCAGGCAGCCTTGAGGTCACCTGGGATCTCGGGGTA GCCAGGCTGCTCCAAGACAGTGGATATCGAGGCAGTCGTGAGGCCCCTACTCCACCTGGGAGCAGGGGAAGGACGTGGTTGCCTGGCCTG GGCTGCGCCCAGCAGCTTCCCCCCAGTCCTGCCCTCCCAGCTGTCGACCCAGATGGGATGTTCGGATCGGTTTGTAATTAAACCTGGGAA >10398_10398_1_BSG-SHC2_BSG_chr19_572701_ENST00000333511_SHC2_chr19_425231_ENST00000264554_length(amino acids)=213AA_BP=22 MAAALFVLLGFALLGTHGASGAAPPGDGYVQADARGPPDHEEHLYVNTQGLDAPEPEDSPKKDLFDMRPFEDALKLHECSVAAGVTAAPL PLEDQWPSPPTRRAPVAPTEEQLRQEPWYHGRMSRRAAERMLRADGDFLVRDSVTNPGQYVLTGMHAGQPKHLLLVDPEGVVRTKDVLFE -------------------------------------------------------------- >10398_10398_2_BSG-SHC2_BSG_chr19_572701_ENST00000353555_SHC2_chr19_425231_ENST00000264554_length(transcript)=1444nt_BP=124nt GCCGCGGGCGGCGGCGGCAGCGGTTGGAGGTTGTAGGACCGGCGAGGAATAGGAATCATGGCGGCTGCGCTGTTCGTGCTGCTGGGATTC GCGCTGCTGGGCACCCACGGAGCCTCCGGGGCTGCTCCACCGGGGGACGGCTACGTGCAGGCGGACGCCCGGGGCCCCCCGGACCACGAG GAGCACCTGTATGTCAACACCCAGGGTCTGGACGCCCCCGAGCCGGAGGACAGCCCCAAAAAGGATCTGTTTGACATGCGACCCTTTGAG GATGCCCTGAAGTTGCATGAGTGCTCAGTGGCGGCAGGCGTGACAGCAGCCCCTCTTCCCTTGGAGGACCAGTGGCCCAGCCCCCCTACC CGCCGGGCCCCTGTGGCCCCCACGGAGGAACAGCTGCGTCAGGAGCCCTGGTACCACGGCCGGATGAGCCGCCGGGCGGCAGAGAGGATG CTTCGAGCTGACGGGGACTTCCTTGTGCGAGACAGCGTCACCAACCCCGGGCAGTATGTCCTCACCGGCATGCACGCCGGGCAGCCCAAG CACCTGCTGCTCGTGGACCCCGAGGGCGTGGTACGGACGAAGGACGTGCTGTTTGAGAGCATCAGCCACCTGATCGACCACCACCTGCAG AACGGGCAGCCCATCGTGGCCGCCGAGAGTGAGCTGCACCTGCGTGGCGTGGTCTCACGGGAGCCCTGAGCCAGGTGACCGTTCTCAGCC CTGGCTCCTGCCTGTTCTCAGCCCCGGCTCCTGCCTGTCATGGCCTTGGGGCTCTCAGCCCTCCTCCTGGATCCTGGTCAGGCCGAACCA CCGCTGCCTCTCCTTCCTCCGCATGAGCCTCTGGCATGGTCCTTCCTCCAGCTGGCCCCGGGCTGGGCAGAGCCTCCTCCTGCCGGGGCC CCTGCCCACCCCCTCCTTTGCCTGGAGTGAGGGTGTTCATACCAAAGACGGAACCATTTCGCCTTTAAAGAAAATATATCCAGAAGCAGC CGCTGCCTCGGAGCCCTGGCCCTTGGGTCCCCCTCTCGCCTGGCTGGTTCGGTCTAACGCCCCGGAGAGTCAGGGCTCCCAGGACCCTGG GGAGGAGGCGGATTCCGGGCCTGGCTGGGCTTCCTCTTCCCACCTGAGGACTGGGTGCACAGTTGTCTTTGAGGGGGGACGCTTAAGGTG CTTTGGGGTTCTCAGGCCAGGATACATGCTGGCGCTGAAGTGCAGGCAGCCTTGAGGTCACCTGGGATCTCGGGGTAGCCAGGCTGCTCC AAGACAGTGGATATCGAGGCAGTCGTGAGGCCCCTACTCCACCTGGGAGCAGGGGAAGGACGTGGTTGCCTGGCCTGGGCTGCGCCCAGC AGCTTCCCCCCAGTCCTGCCCTCCCAGCTGTCGACCCAGATGGGATGTTCGGATCGGTTTGTAATTAAACCTGGGAATGGCCACAAGAGC >10398_10398_2_BSG-SHC2_BSG_chr19_572701_ENST00000353555_SHC2_chr19_425231_ENST00000264554_length(amino acids)=213AA_BP=22 MAAALFVLLGFALLGTHGASGAAPPGDGYVQADARGPPDHEEHLYVNTQGLDAPEPEDSPKKDLFDMRPFEDALKLHECSVAAGVTAAPL PLEDQWPSPPTRRAPVAPTEEQLRQEPWYHGRMSRRAAERMLRADGDFLVRDSVTNPGQYVLTGMHAGQPKHLLLVDPEGVVRTKDVLFE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for BSG-SHC2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for BSG-SHC2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for BSG-SHC2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies